Related Experiment Video
Updated: Jul 25, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Discontinuation of Car Seat Tolerance Screening and Postdischarge Adverse Outcomes in Infants Born Preterm
David Braun1, Joseph W Kaempf2, Ngoc J Ho3
1Department of Neonatal-Perinatal Medicine, Southern California Permanente Medical Group, Pasadena, CA; Department of Research and Evaluation, Southern California Permanente Medical Group, Pasadena, CA.
Insights
Discontinuing car seat tolerance screening (CSTS) for preterm infants did not increase 30-day postdischarge adverse outcomes. Further evaluation is needed to determine the value of CSTS as a standard assessment.
Area of Science:
- Neonatology
- Pediatric Health Outcomes
- Health Services Research
Background:
- Car seat tolerance screening (CSTS) is a predischarge assessment for preterm infants.
- The clinical utility and impact of discontinuing CSTS on infant safety after discharge require investigation.
Purpose of the Study:
- To examine the association between discontinuing predischarge car seat tolerance screening (CSTS) and 30-day postdischarge adverse outcomes in preterm infants.
Main Methods:
- A retrospective cohort study was conducted in a 14-hospital integrated health care system.
- Infants born preterm between 2010-2021 were analyzed, comparing outcomes during periods with and without CSTS.
- The primary outcome was a composite of death, 911 call-triggered transports, or readmissions for specific respiratory and cardiorespiratory events within 30 days of discharge.
Main Results:
- The unadjusted primary outcome rate was 1.02% with CSTS and 1.06% after discontinuation (P=.76).
- Adjusted odds ratio was 0.95 (95% CI: 0.75-1.19), indicating no significant difference.
- No statistically significant differences were observed in outcome components, gestational age strata, or NICU admission status.
Conclusions:
- Discontinuation of CSTS in a large health care network was not linked to increased 30-day postdischarge adverse events in preterm infants.
- The findings suggest that CSTS may not be essential for all preterm infants before discharge.
- Further research is warranted to evaluate the ongoing value of CSTS as a standard predischarge assessment.
Objective:
To study the association between discontinuing predischarge car seat tolerance screening (CSTS) with 30-day postdischarge adverse outcomes in infants born preterm.
Study Design:
Retrospective cohort study involving all infants born preterm from 2010 through 2021 who survived to discharge to home in a 14-hospital integrated health care system. The exposure was discontinuation of CSTS. The primary outcome was a composite rate of death, 911 call-triggered transports, or readmissions associated with diagnostic codes of respiratory disorders, apnea, apparent life-threatening event, or brief resolved unexplained events within 30 days of discharge. Outcomes of infants born in the periods of CSTS and after discontinuation were compared.
Results:
Twelve of 14 hospitals initially utilized CSTS and contributed patients to the CSTS period; 71.4% of neonatal intensive care unit (NICU) patients and 26.9% of non-NICU infants were screened. All hospitals participated in the discontinuation period; 0.1% was screened. Rates of the unadjusted primary outcome were 1.02% in infants in the CSTS period (n = 21 122) and 1.06% after discontinuation (n = 20 142) (P = .76). The aOR (95% CI) was 0.95 (0.75, 1.19). Statistically insignificant differences between periods were observed in components of the primary outcome, gestational age strata, NICU admission status groups, and other secondary analyses.
Conclusions:
Discontinuation of CSTS in a large integrated health care network was not associated with a change in 30-day postdischarge adverse outcomes. CSTS's value as a standard predischarge assessment deserves further evaluation.
Related Concept Videos
Teratogenicity
Discharge Summary Forms
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Endoscopic Studies II: Thoracocentesis
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...

